Skip to playerSkip to main content
  • 1 year ago
This session will cover the major routes to regulatory approval in the EU and US with a focus on Intended Use for Software as a Medical Device (SaMD), Good Machine Learning Practice (GMLP), and Post Market Surveillance (PMS).
Be the first to comment
Add your comment

Recommended